Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10

NCT ID: NCT06517927

Last Updated: 2024-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

142 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-03

Study Completion Date

2026-05-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To date, there are no methods for assessing the risk of oral developmental defects that could predict long-term adverse effects in childhood cancer survivors. Having such a method at our disposal would enable us to better assess the risk to develop those defects and will help us provide new prevention and treatment strategies to ensure a healthy oral development.

The aims of this study are :

* Assess the caries risk in childhood cancer survivors compared with a control group.
* Assess the dental development defects risk in childhood cancer survivors compared with a control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be an international study comparing the Childhood Cancer Survivors (CCS) and a control group.

A questionnaire will be provided to the patients to gather information. A standard of care dental examination will then take place in a dental office in the Cliniques Universitaires Saint-Luc. We also collect medical data to complete the files.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chemotherapy Effect Dental Caries Malocclusion Childhood Cancer Tooth Defect

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Interventionnal study, cohort study
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cancer survivor

Group Type EXPERIMENTAL

Clinical and radiographic dental examination

Intervention Type DIAGNOSTIC_TEST

complete clinical oral examination + intra-oral and panoramic x-rays

Control

Group Type ACTIVE_COMPARATOR

Clinical and radiographic dental examination

Intervention Type DIAGNOSTIC_TEST

complete clinical oral examination + intra-oral and panoramic x-rays

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical and radiographic dental examination

complete clinical oral examination + intra-oral and panoramic x-rays

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age below 10 at cancer diagnosis (for the CCS group).
* Chemotherapy must have been used to treat the patient (For the CCS group).
* The patient is 12 years old or older at the time of the follow-up appointment of the present study

Exclusion Criteria

* A patient who was diagnosed and treated after 10 years old.
* Patient below 12 years old at time of study recruitment
* Patients with syndrome or diseases that involve teeth impairment\*
* Pregnant patient
* Refusal or inaptitude to undergo dental and radiographic examination
Minimum Eligible Age

12 Years

Maximum Eligible Age

36 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maëlle De Ville de Goyet

Role: PRINCIPAL_INVESTIGATOR

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques universitaires Saint-Luc

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Armand IRAKOZE

Role: CONTACT

027645741 ext. +32

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maëlle De Ville de Goyet

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DENTAL CHEMO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.